ReShape Lifesciences Inc. (RSLS)
USD 4.5
(-4.46%)
USD 4.5
(-4.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.67 Million | 11.24 Million | 13.6 Million | 11.29 Million | 15.08 Million | 606.71 Thousand |
| Cost of Revenue | 3.13 Million | 4.43 Million | 5.25 Million | 5.03 Million | 5.78 Million | 164.29 Thousand |
| Gross Profit | 5.54 Million | 6.8 Million | 8.34 Million | 6.26 Million | 9.3 Million | 442.41 Thousand |
| Operating Expenses | 20.18 Million | 33.88 Million | 36.09 Million | 18.71 Million | 25.19 Million | 24.98 Million |
| Selling, General and Administrative Expenses | 17.87 Million | 31.34 Million | 33.57 Million | 15.22 Million | 22.07 Million | 19.26 Million |
| Research and Development Expenses | 2.31 Million | 2.53 Million | 2.52 Million | 3.49 Million | 3.12 Million | 5.72 Million |
| Other Expenses | - | 11 Thousand | 23.5 Million | 306 Thousand | -1.33 Million | -10.64 Thousand |
| Cost and Expenses | 23.31 Million | 38.31 Million | 41.34 Million | 23.75 Million | 30.97 Million | 25.14 Million |
| Operating Income | -14.63 Million | -27.07 Million | -27.74 Million | -12.45 Million | -15.88 Million | -38.54 Million |
| Interest Expense | - | 113 Thousand | 832 Thousand | 2.04 Million | 451 Thousand | 12.37 Thousand |
| Income Tax Expense | 52 Thousand | -380 Thousand | -106 Thousand | -181 Thousand | -893 Thousand | -3.44 Million |
| Earnings before Tax | -11.33 Million | -46.59 Million | -62.03 Million | -21.81 Million | -75.1 Million | -38.71 Million |
| Net Income | -11.38 Million | -46.21 Million | -61.93 Million | -21.63 Million | -74.2 Million | -81.15 Million |
| Earnings Per Share Basic | -110.88 | -6316.20 | -16.43 Thousand | -48.19 Thousand | -137.16 Thousand | -370.87 Thousand |
| Earnings Per Share Diluted | -110.88 | -6316.20 | -16.43 Thousand | -48.19 Thousand | -137.16 Thousand | -370.87 Thousand |
| Weighted Average Shares Outstanding | 102.69 Thousand | 7317.07 | 3767.62 | 1346.43 | 1623.00 | 218.81 |
| Weighted Average Shares Outstanding (Diluted) | 102.69 Thousand | 7317.07 | 3767.62 | 1346.43 | 1623.00 | 218.81 |
| Gross Margin | 0.64 | 0.61 | 0.61 | 0.55 | 0.62 | 0.73 |
| EBIT Margin | -1.67 | -2.22 | -2.04 | -1.10 | -1.14 | -39.74 |
| Profit Margin | -1.31 | -4.11 | -4.55 | -1.91 | -4.92 | -133.76 |
| EBITDA | -14.48 Million | -24.92 Million | -60.61 Million | -18.09 Million | -17.22 Million | -36.96 Million |
| Earnings Before Tax Margin | -1.69 | -2.41 | -2.04 | -1.10 | -1.05 | -63.53 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.96 Million | 1.94 Million | 1.98 Million | 8.67 Million | 2.15 Million | 2.25 Million |
| Cost of Revenue | 831 Thousand | 779 Thousand | 140 Thousand | 3.13 Million | 867 Thousand | 1.06 Million |
| Gross Profit | 1.13 Million | 1.16 Million | 1.84 Million | 5.54 Million | 1.28 Million | 1.19 Million |
| Operating Expenses | 3.18 Million | 3.37 Million | 3.73 Million | 20.18 Million | 4.39 Million | 5.2 Million |
| Selling, General and Administrative Expenses | 2.78 Million | 2.89 Million | 2.99 Million | - | 3.84 Million | 4.62 Million |
| Research and Development Expenses | 399 Thousand | 484 Thousand | 739 Thousand | - | 542 Thousand | 581 Thousand |
| Other Expenses | 59 Thousand | 25 Thousand | 114 Thousand | 122 Thousand | - | 6000.00 |
| Cost and Expenses | 4.01 Million | 4.15 Million | 3.87 Million | 23.31 Million | 5.25 Million | 6.26 Million |
| Operating Income | -2.05 Million | -2.21 Million | -1.89 Million | -14.63 Million | -3.1 Million | -3.97 Million |
| Interest Expense | - | -9000.00 | -31 Thousand | -26 Thousand | - | - |
| Income Tax Expense | 15 Thousand | 14 Thousand | 31 Thousand | 52 Thousand | 3000.00 | 4000.00 |
| Earnings before Tax | -1.58 Million | -2.17 Million | -1.66 Million | -11.33 Million | -3.53 Million | -3.48 Million |
| Net Income | -1.59 Million | -2.19 Million | -1.69 Million | -11.38 Million | -3.53 Million | -3.49 Million |
| Earnings Per Share Basic | -0.06 | -0.09 | -0.07 | - | -1.02 | -1.08 |
| Earnings Per Share Diluted | -0.06 | -0.09 | -0.07 | - | -1.02 | -1.08 |
| Weighted Average Shares Outstanding | 25.22 Million | 23.45 Million | 23.45 Million | 5.95 Million | 3.45 Million | 3.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.22 Million | 23.45 Million | 23.45 Million | 5.95 Million | 3.45 Million | 3.24 Million |
| Gross Margin | 0.58 | 0.60 | 0.93 | 0.64 | 0.60 | 0.53 |
| EBIT Margin | -1.04 | -1.14 | -0.95 | - | -1.44 | -1.98 |
| Profit Margin | -0.81 | -1.13 | -0.86 | -1.31 | -1.64 | -1.55 |
| EBITDA | -2.04 Million | -2.21 Million | -1.88 Million | - | -3.1 Million | -4.46 Million |
| Earnings Before Tax Margin | -1.05 | -1.14 | -0.96 | -1.69 | -1.44 | -1.76 |
BYAN
002374
6790
LANDO
ALSEA
VISL